Clinical Trial Update: Study of NXN 188 for the Treatment of Migraine With Aura [Phase 2]

View source ↗

Summary

This document notes the completion of a Phase 2 clinical trial of NXN 188 for migraine with aura. Results from the study were posted on 2014-08-11.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine with Aura

Drugs mentioned

• NXN 188

Snippet

Sponsor: NeurAxon Inc. | Conditions: Migraine With Aura | Phase 2 | Status: COMPLETED | Results posted: 2014-08-11